These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 35179319)

  • 1. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL1 promotes hepatocarcinogenesis via m
    Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
    Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WDR4 promotes HCC pathogenesis through N
    Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
    Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Han H; Yang C; Ma J; Zhang S; Zheng S; Ling R; Sun K; Guo S; Huang B; Liang Y; Wang L; Chen S; Wang Z; Wei W; Huang Y; Peng H; Jiang YZ; Choe J; Lin S
    Nat Commun; 2022 Mar; 13(1):1478. PubMed ID: 35304469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL1-mediated tRNA m
    Du D; Zhou M; Ju C; Yin J; Wang C; Xu X; Yang Y; Li Y; Cui L; Wang Z; Lei Y; Li H; He F; He J
    J Exp Clin Cancer Res; 2024 May; 43(1):154. PubMed ID: 38822363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL1/WDR4-mediated m
    Ma J; Han H; Huang Y; Yang C; Zheng S; Cai T; Bi J; Huang X; Liu R; Huang L; Luo Y; Li W; Lin S
    Mol Ther; 2021 Dec; 29(12):3422-3435. PubMed ID: 34371184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mettl1/Wdr4-Mediated m
    Lin S; Liu Q; Lelyveld VS; Choe J; Szostak JW; Gregory RI
    Mol Cell; 2018 Jul; 71(2):244-255.e5. PubMed ID: 29983320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
    Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL1/WDR4-mediated tRNA m
    Wang Z; Yu P; Zou Y; Ma J; Han H; Wei W; Yang C; Zheng S; Guo S; Wang J; Liu L; Lin S
    Oncogene; 2023 Jun; 42(23):1900-1912. PubMed ID: 37185458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
    Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
    Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N
    Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
    Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N
    Han H; Zheng S; Lin S
    Autophagy; 2023 Jan; 19(1):360-362. PubMed ID: 35574843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of regulated m
    Li J; Wang L; Hahn Q; Nowak RP; Viennet T; Orellana EA; Roy Burman SS; Yue H; Hunkeler M; Fontana P; Wu H; Arthanari H; Fischer ES; Gregory RI
    Nature; 2023 Jan; 613(7943):391-397. PubMed ID: 36599985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL1-mediated m
    Orellana EA; Liu Q; Yankova E; Pirouz M; De Braekeleer E; Zhang W; Lim J; Aspris D; Sendinc E; Garyfallos DA; Gu M; Ali R; Gutierrez A; Mikutis S; Bernardes GJL; Fischer ES; Bradley A; Vassiliou GS; Slack FJ; Tzelepis K; Gregory RI
    Mol Cell; 2021 Aug; 81(16):3323-3338.e14. PubMed ID: 34352207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting N
    Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
    Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL1 mediated tRNA m
    Zhao P; Xia L; Chen D; Xu W; Guo H; Xu Y; Yan B; Wu X; Li Y; Zhang Y; Zhang X
    Exp Hematol Oncol; 2024 Jan; 13(1):8. PubMed ID: 38268051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel roles of METTL1/WDR4 in tumor via m
    Cheng W; Gao A; Lin H; Zhang W
    Mol Ther Oncolytics; 2022 Sep; 26():27-34. PubMed ID: 35784404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL1 promotes neuroblastoma development through m
    Huang Y; Ma J; Yang C; Wei P; Yang M; Han H; Chen HD; Yue T; Xiao S; Chen X; Li Z; Tang Y; Luo J; Lin S; Huang L
    Biomark Res; 2022 Sep; 10(1):68. PubMed ID: 36071474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures and mechanisms of tRNA methylation by METTL1-WDR4.
    Ruiz-Arroyo VM; Raj R; Babu K; Onolbaatar O; Roberts PH; Nam Y
    Nature; 2023 Jan; 613(7943):383-390. PubMed ID: 36599982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
    Xia P; Zhang H; Xu K; Jiang X; Gao M; Wang G; Liu Y; Yao Y; Chen X; Ma W; Zhang Z; Yuan Y
    Cell Death Dis; 2021 Jul; 12(7):691. PubMed ID: 34244479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.